Tsampras Nikolaos, Ma Kenneth, Arora Rohit, McLeod Gemma, Minchelotti Flurina, Craciunas Laurentiu
Department of Gynaecology, Manchester University Foundation Trust, Manchester, UK.
Department of Gynaecology, Manchester University Foundation Trust, Manchester, UK.
Eur J Obstet Gynecol Reprod Biol. 2021 May;260:110-113. doi: 10.1016/j.ejogrb.2021.03.022. Epub 2021 Mar 17.
More than 60,000 hysteroscopies are performed every year in the UK for common reasons such as heavy menstrual bleeding (HMB) or postmenopausal bleeding. A significant number of women requiring hysteroscopy receive oral anticoagulants and there is often a reluctance to perform these procedures due to bleeding concerns.
We are presenting the first proof of concept cohort of patients undergoing minor hysteroscopic procedures while on anticoagulant or antiplatelet medication. A variety of minor procedures such as cervical dilatation, targeted endometrial biopsies, Pipelle endometrial biopsies and insertion or removal of intrauterine contraceptive devices were performed alongside hysteroscopy.
Completion of planned procedures was feasible in all women due to minimal bleeding despite the ongoing anticoagulation or anti-platelet treatment.
More research is needed to establish the safety of performing diagnostic and operative hysteroscopies without bridging or interrupting anticoagulation or antiplatelet treatment.
在英国，每年有超过6万例宫腔镜检查因月经过多（HMB）或绝经后出血等常见原因进行。大量需要宫腔镜检查的女性正在服用口服抗凝剂，并且由于出血问题，人们通常不愿进行这些手术。
我们展示了首个在接受抗凝或抗血小板药物治疗的同时进行小型宫腔镜手术的患者概念验证队列。在宫腔镜检查的同时进行了各种小型手术，如宫颈扩张、靶向子宫内膜活检、 Pipelle子宫内膜活检以及宫内节育器的插入或取出。
尽管正在进行抗凝或抗血小板治疗，但由于出血极少，所有女性完成计划手术都是可行的。
需要更多研究来确定在不进行桥接或中断抗凝或抗血小板治疗的情况下进行诊断性和手术性宫腔镜检查的安全性。
